Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28799560 | 0.90 | AKR1C3 (0.41) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL14718115 | 0.89 | HMGB1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL10782556 | 0.87 | PARP1 (0.37) | ALDH1A1TSHR | |
| SCHEMBL2778676 | 0.82 | ALDH1A1 (0.39) | DHFRALDH1A1TP53CYP3A4TSHR | |
| SCHEMBL16694408 | 0.80 | — | — | |
| SCHEMBL11063026 | 0.77 | HSPA5 (0.34) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| Nitrilotriacetic Acid SCHEMBL2778509 | 0.76 | TDP1 (0.42) | TSHRHIF1AMGLL | |
| SCHEMBL10703033 | 0.76 | PARP1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL2289368 | 0.76 | FOLH1 (0.49) | ALDH1A1TP53TSHRSMN1; SMN2HIF1A | |
| SCHEMBL10626070 | 0.75 | AKR1C3 (0.46) | ALDH1A1SMN1; SMN2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024160661-A1 | TWO-COMPONENT EPOXY RESIN COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2024-08-08 | — | — | WO | claimed |
| EP-4406989-A1 | TWO-COMPONENT EPOXY RESIN COMPOSITION | Henkel AG & Co. KGaA (DE) | 2024-07-31 | — | — | EP | claimed |
| US-10280346-B2 | One-part curable adhesive composition and the use thereof | HENKEL AG & CO. KGAA (DE) | 2019-05-07 | — | — | US | claimed |
| EP-3289038-A1 | A ONE-PART CURABLE ADHESIVE COMPOSITIONAND THE USE THEREOF | Henkel AG & Co. KGaA (DE) | 2018-03-07 | — | — | EP | claimed |
| US-20180044565-A1 | ONE-PART CURABLE ADHESIVE COMPOSITION AND THE USE THEREOF | HENKEL AG & CO. KGAA (DE) | 2018-02-15 | — | — | US | claimed |
| WO-2016172911-A1 | A ONE-PART CURABLE ADHESIVE COMPOSITIONAND THE USE THEREOF | HENKEL AG & CO. KGAA (DE) | 2016-11-03 | — | — | WO | claimed |
| US-5317068-A | Matrix for fiber reinforced composites; good tack and drape | TONEN CORPORATION (JP) | 1994-05-31 | — | — | US | claimed |
| EP-0411834-B1 | Epoxy resin composition | TONEN CORP (JP) | 1994-02-02 | — | — | EP | claimed |
| EP-0411834-A2 | Epoxy resin composition | Tonen Corporation (JP) | 1991-02-06 | — | — | EP | claimed |
| US-12570858-B2 | Curable composition, cured product, cured film, display panel, and method for producing cured film | TOKYO OHKA KOGYO CO., LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20240402602-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| US-20240384056-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-11-21 | — | — | US | disclosed |
| US-12139567-B2 | Curable composition, cured product, and compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-11-12 | — | — | US | disclosed |
| US-12129335-B2 | Curable composition, cured product, and compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-10-29 | — | — | US | disclosed |
| US-5273826-A | Polyurethane containing phosphorus groups as binder | THE B. F. GOODRICH COMPANY (US) | 1993-12-28 | — | — | US | disclosed |
| US-5162162-A | Polyurethanes containing phosphorous compounds, epoxides and isocyanates; durability, wear resistance | THE B. F. GOODRICH COMPANY (US) | 1992-11-10 | — | — | US | disclosed |
| US-5158830-A | Magnetic recording medium comprising a polyurethane resin coating residual groups derived from specified phosphorous containing compounds | THE B. F. GOODRICH COMPANY (US) | 1992-10-27 | — | — | US | disclosed |
| US-5037934-A | Polyurethane resin binder from epoxy, isocyanates, phosphoric acid and polyhydroxy components; durability | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
| EP-0411834-A2 | Epoxy resin composition | Tonen Corporation (JP) | 1991-02-06 | — | — | EP | disclosed |
| EP-0367667-A2 | A new polyurethane resin containing at least one phosphoric acid group and its use in a magnetic coating formulation and a magnetic recording medium | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1990-05-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12139567-B2 | Curable composition, cured product, and compound | CROCC, RCSD1, CRYZ | DHFR 1598/4885ALDH1A1 2462/4885TP53 3301/4885 |
| US-12570858-B2 | Curable composition, cured product, cured film, display panel, and method for producing cured film | C5, CFL1, C9 | DHFR 4435/4885ALDH1A1 1968/4885TP53 2036/4885 |
| US-20240402602-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | CHMP4B, PHOSPHO1, EXOSC9 | DHFR 3455/4885ALDH1A1 2515/4885TP53 3240/4885 |
| US-20240384056-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | CHMP4B, PHOSPHO1, EXOSC9 | DHFR 3450/4885ALDH1A1 2498/4885TP53 3296/4885 |
| US-12129335-B2 | Curable composition, cured product, and compound | CROCC, RCSD1, WDR5 | DHFR 1140/4885ALDH1A1 1884/4885TP53 3407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.